Skip to main content
. 2016 Mar 3;6:22338. doi: 10.1038/srep22338

Figure 2. Relative proportions of genomic aberrations in lung adenocarcinoma (N = 58).

Figure 2

(A) Actionable variants and gene frequencies detected in 58 prospective samples. (B) Distribution of the patients according to the classification of detected actionable mutations.